Launch-of-CARE-Consortium

Europe ’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus ThreatsCARE (Corona Accelerated R&D in Europe), supported by Europe ’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19The initiative is committed to a long-term understanding of the disease and development of therapies for COVID-19 and future coronavirus threats in addition to urgent efforts to repurpose existing therapies as potential immediate response.The CARE consortium will accelerate COVID-19 R&D by bringing together the leading expertise and projects of 37 teams from academic and non-profit research institutions and pharmaceutical companies into a comprehensive drug discovery engine.   
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news